Login / Signup
GLP-1 receptor agonists and SGLT-2 inhibitors as adjuncts to insulin in Type 1 diabetes: benefits and concerns.
George D Dimitriadis
Vaia Lambadiari
Published in:
The Journal of clinical endocrinology and metabolism (2022)
Keyphrases
</>
type diabetes
glycemic control
insulin resistance
cardiovascular disease
adipose tissue